Tell a Friend | SmartBrief

Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.

Referral Count:

Story being shared

FDA OKs Mylan's generic migraine tablets

Mylan Pharmaceuticals has won FDA approval for its rizatriptan benzoate orally disintegrating tablets and rizatriptan benzoate tablets to address migraine with or without aura in adults. The drugs are generic formulations of Merck's Maxalt MLT and Maxalt.

Or we can send an email on your behalf

Your name(s)

Your email

Your friend's email

Message

Agree to Terms & Conditions

You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .